Body weight loss is a simple and useful indicator of prognosis and predictive tolerability in the first year of nintedanib therapy in patients with interstitial lung disease
Article in Respiratory Investigation (April 2024)
The most recent citing publications are shown below. View all 47 publications that cite this research output on Dimensions.
Article in Respiratory Investigation (April 2024)
Article in Respiratory Investigation (March 2024)
Article in Respiratory Medicine (February 2024)